Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019 Maastricht, the Netherlands

Hubert J. M. Smeets; Bram Verbrugge; Pierre Springuel; Nicol C. Voermans; MDC1A Workshop Group

doi:10.1016/j.nmd.2021.04.003

Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019 Maastricht, the Netherlands

Hubert J. M. Smeets^*, Bram Verbrugge, Pierre Springuel, Nicol C. Voermans, MDC1A Workshop Group

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	673-680
Number of pages	8
Journal	Neuromuscular Disorders
Volume	31
Issue number	7
DOIs	https://doi.org/10.1016/j.nmd.2021.04.003
Publication status	Published - Jul 2021

Keywords

MOUSE MODEL

Access to Document

10.1016/j.nmd.2021.04.003

Cite this

@article{fad31833ac1d42439fc1030c438d0d0f,

title = "Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019 Maastricht, the Netherlands",

keywords = "MOUSE MODEL",

author = "Smeets, {Hubert J. M.} and Bram Verbrugge and Pierre Springuel and Voermans, {Nicol C.} and {MDC1A Workshop Group}",

note = "Funding Information: Organization of the workshop was supported by a contribution of the foundation “Voor Sara” (www.mdc1a.com) and research school MHeNS of Maastricht University (www.maastrichtuniversity.nl/research/school-mental-health-and-neuroscience). Giulio Cossu (University of Manchester, Manchester, UK), Ren{\'e} de Coo (Maastricht University, Maastricht, NL), Christos Diamantidis (Maastricht University, Maastricht, NL), Eric Dragendorf (Maastricht University, Maastricht, NL), Madeleine Durbeej-Hjalt (Lund University, Lund, SE), Gustavo Dziewczapolski (Cure CMD, San Diego, US), Corrie Erasmus (RadboudUMC, Nijmegen, NL), Reghan Foley (NIH, Bethesda, USA), Sweta Girgenrath (University of Massachusetts Medical School, Worcester, US), Leonardo Zingler Herrero (Maastricht University, Maastricht, NL), Dwi Kemaladewi (Children's Hospital of Pittsburgh, Pittsburgh, US), Andrea Klein (University of Z{\"u}rich, Z{\"u}rich, CH), Marie-Julie Lemmens (Maastricht University, Maastricht, NL), Lotte van de Loo (Maastricht University, Maastricht, NL), Stefano Previtali (IRCCS San Raffaele Scientific Institute Milan, IT), Markus Ruegg (University of Basel, Basel, CH), Adnan Abdulaziz Said (Maastricht University, Maastricht, NL), Maurilio Sampaolesi (KU Leuven, Leuven, BE), Anna Sarkozy (Dubowitz Neuromuscular Centre, London, UK), Hemant Sawnani (University of Cincinnati, Cincinnati, US), Dirk Jan Stelwagen (Patient representative, Amsterdam, NL), Heleen Stelwagen (Patient representative, Groningen, NL), Haluk Topaloglu (Hacettepe University School of Medicine, Ankara, TR), Florence van Tienen (Maastricht University, Maastricht, NL), Peter Yurchenco (Robert Wood Johnson Medical School, Piscataway, US), Teun van Zutphen (Maastricht University, Maastricht, NL)",

year = "2021",

month = jul,

doi = "10.1016/j.nmd.2021.04.003",

language = "English",

volume = "31",

pages = "673--680",

journal = "Neuromuscular Disorders",

issn = "0960-8966",

publisher = "Elsevier Ltd",

number = "7",

}

TY - JOUR

T1 - Merosin deficient congenital muscular dystrophy type 1A

T2 - An international workshop on the road to therapy 15-17 November 2019 Maastricht, the Netherlands

AU - Smeets, Hubert J. M.

AU - Verbrugge, Bram

AU - Springuel, Pierre

AU - Voermans, Nicol C.

AU - MDC1A Workshop Group

N1 - Funding Information: Organization of the workshop was supported by a contribution of the foundation “Voor Sara” (www.mdc1a.com) and research school MHeNS of Maastricht University (www.maastrichtuniversity.nl/research/school-mental-health-and-neuroscience). Giulio Cossu (University of Manchester, Manchester, UK), René de Coo (Maastricht University, Maastricht, NL), Christos Diamantidis (Maastricht University, Maastricht, NL), Eric Dragendorf (Maastricht University, Maastricht, NL), Madeleine Durbeej-Hjalt (Lund University, Lund, SE), Gustavo Dziewczapolski (Cure CMD, San Diego, US), Corrie Erasmus (RadboudUMC, Nijmegen, NL), Reghan Foley (NIH, Bethesda, USA), Sweta Girgenrath (University of Massachusetts Medical School, Worcester, US), Leonardo Zingler Herrero (Maastricht University, Maastricht, NL), Dwi Kemaladewi (Children's Hospital of Pittsburgh, Pittsburgh, US), Andrea Klein (University of Zürich, Zürich, CH), Marie-Julie Lemmens (Maastricht University, Maastricht, NL), Lotte van de Loo (Maastricht University, Maastricht, NL), Stefano Previtali (IRCCS San Raffaele Scientific Institute Milan, IT), Markus Ruegg (University of Basel, Basel, CH), Adnan Abdulaziz Said (Maastricht University, Maastricht, NL), Maurilio Sampaolesi (KU Leuven, Leuven, BE), Anna Sarkozy (Dubowitz Neuromuscular Centre, London, UK), Hemant Sawnani (University of Cincinnati, Cincinnati, US), Dirk Jan Stelwagen (Patient representative, Amsterdam, NL), Heleen Stelwagen (Patient representative, Groningen, NL), Haluk Topaloglu (Hacettepe University School of Medicine, Ankara, TR), Florence van Tienen (Maastricht University, Maastricht, NL), Peter Yurchenco (Robert Wood Johnson Medical School, Piscataway, US), Teun van Zutphen (Maastricht University, Maastricht, NL)

PY - 2021/7

Y1 - 2021/7

KW - MOUSE MODEL

U2 - 10.1016/j.nmd.2021.04.003

DO - 10.1016/j.nmd.2021.04.003

M3 - Article

C2 - 34130888

SN - 0960-8966

VL - 31

SP - 673

EP - 680

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

IS - 7

ER -